Polypharmacy definition and prevalence in heart failure: a systematic review
Polypharmacy and heart failure are becoming increasingly common due to an ageing
population and the rise of multimorbidity. Treating heart failure necessitates prescribing of …
population and the rise of multimorbidity. Treating heart failure necessitates prescribing of …
Deprescribing in older adults with cardiovascular disease
A Krishnaswami, MA Steinman, P Goyal… - Journal of the American …, 2019 - jacc.org
Deprescribing, an integral component of a continuum of good prescribing practices, is the
process of medication withdrawal or dose reduction to correct or prevent medication-related …
process of medication withdrawal or dose reduction to correct or prevent medication-related …
Virtual visits for care of patients with heart failure in the era of COVID-19: a statement from the Heart Failure Society of America
EZ Gorodeski, P Goyal, ZL Cox, JT Thibodeau… - Journal of Cardiac …, 2020 - Elsevier
In response to the COVID-19 pandemic, US federal and state governments have
implemented wide-ranging stay-at-home recommendations as a means to reduce spread of …
implemented wide-ranging stay-at-home recommendations as a means to reduce spread of …
Both new and chronic potentially inappropriate medications continued at hospital discharge are associated with increased risk of adverse events
BACKGROUND Admission to hospital provides the opportunity to review patient
medications; however, the extent to which the safety of drug regimens changes after …
medications; however, the extent to which the safety of drug regimens changes after …
Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction according to polypharmacy status
A Peikert, P Goyal, M Vaduganathan, BL Claggett… - Heart Failure, 2023 - jacc.org
Background Patients with heart failure (HF) have a high burden of multimorbidity, often
necessitating numerous medications. There may be clinical concern about introducing …
necessitating numerous medications. There may be clinical concern about introducing …
[HTML][HTML] Clinical perspectives on cardiac rehabilitation after heart failure in elderly patients with frailty: a narrative review
D Tsukakoshi, S Yamamoto, S Takeda… - … and Clinical Risk …, 2022 - ncbi.nlm.nih.gov
The purpose of this narrative review is to examine rehabilitation modalities for patients with
heart failure and Frailty who require comprehensive intervention. Ischemic heart disease is …
heart failure and Frailty who require comprehensive intervention. Ischemic heart disease is …
Prevalence and determinants of Hyperpolypharmacy in adults with heart failure: an observational study from the National Health and Nutrition Examination Survey …
Background While an expanding armamentarium of pharmacologic therapies has
contributed to improved outcomes among adults with heart failure (HF) over the past two …
contributed to improved outcomes among adults with heart failure (HF) over the past two …
Social determinants of health and 30-day readmissions among adults hospitalized for heart failure in the REGARDS study
Background: It is not known which social determinants of health (SDOH) impact 30-day
readmission after a heart failure (HF) hospitalization among older adults. We examined the …
readmission after a heart failure (HF) hospitalization among older adults. We examined the …
Cognitive impairment in heart failure: A Heart Failure Society of America scientific statement
Cognitive impairment is common among adults with heart failure (HF), as both diseases are
strongly related to advancing age and multimorbidity (including both cardiovascular and …
strongly related to advancing age and multimorbidity (including both cardiovascular and …
[PDF][PDF] Influence of polypharmacy on patients with heart failure with preserved ejection fraction: a retrospective analysis on adverse outcomes in the TOPCAT trial
Y Wu, W Zhu, X He, R Xue, W Liang, F Wei… - British Journal of …, 2020 - bjgp.org
Background Polypharmacy is common in heart failure (HF), whereas its effect on adverse
outcomes in patients with HF with preserved ejection fraction (HFpEF) is unclear. Aim To …
outcomes in patients with HF with preserved ejection fraction (HFpEF) is unclear. Aim To …